GlaxoSmithKline has announced the purchase of 306,478 of its own ordinary shares as part of its ongoing buyback programme. This transaction, executed through Merrill Lynch International, is part of a ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK plc announced the acquisition of ordinary shares by several key executives under the ...

GSK Egypt posted non-consolidated net profits after tax of EGP 71.33 million in H1-25, an annual drop from EGP 99.54 million. Meanwhile, the EPS declined to EGP 0.85 from EGP 1.19. In April-June 2025, ...

Arab Finance: GlaxoSmithKline Egypt (GSK–Egypt) logged consolidated net profits for controlling interest of EGP 65.060 ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...

UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its current portfolio. While the company’s total sales in this period totalled £8bn ...

GlaxoSmithKline PLC leaders and executives have shown their dedication by being a leading pharmaceutical company and research and development firm. GSK was named one of the 100 Best Companies for ...

After its own COVID-19 vaccine setback, GlaxoSmithKline has inked a $180 million deal to help German biotech company CureVac manufacture 100 million doses of its mRNA vaccine, which is currently ...

Jan 15 (Reuters) - GlaxoSmithKline (GSK.L) on Saturday said it had rejected a 50-billion-pound offer from Unilever (ULVR.L) for its consumer goods arm, saying it "fundamentally undervalued" the ...

NurPhoto via Getty Images On April 27, 2022, GlaxoSmithKline GSK -2.9% plc (NYSE: GSK, $45.44, Market Capitalization: $115.5 billion) reported 1Q22 results.

LONDON—With its second-quarter report Wednesday, GlaxoSmithKline PLC GSK -1.52% has pivoted investors toward future expansion following its $20 billion asset swap with Novartis AG, saying it is ...